Scandinavian ChemoTech AB (publ) financials at a glance

The revenue of Scandinavian ChemoTech AB (publ) is reported as 0.00282 billion Kronor in the fiscal year 2023. The earnings were -1.56 Kronor per share in 2023, which was 23.9 higher than 2021. And about -0.02156 billion Kronor are reported as free cash flow in the financials of Scandinavian ChemoTech AB (publ) 2023. No dividends were paid to the shareholders of the Scandinavian ChemoTech AB (publ) stock OM:CMOTEC B in the financial year 2023.